跳至主要内容
临床试验/NCT02761837
NCT02761837已完成不适用

The Breathe Well Program to Improve Asthma Outcomes

National Jewish Health1 个研究点 分布在 1 个国家目标入组 14,978 人开始时间: 2016年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
14,978
试验地点
1
主要终点
Asthma Exacerbations

研究概览

简要总结

The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.

详细描述

Breathe Well uses the Kaiser Permanente Electronic Health Record (EHR) to identify asthma exacerbation risk factors. For patients with a history of frequent exacerbations or B-agonist overuse, the EHR notifies a nurse who uses an EHR-generated tailored clinical report and patient directed decision support tool to engage and empower patients to develop an action plan in collaboration with providers. EHR-templated notes and order sets facilitate care plan execution. Poor controller medication adherence or unaddressed smoking results in the patient being automatically enrolled in an IBCT medication refill or smoking cessation program. Breathe Well uses multiple EHR functions and a patient and provider team to address barriers to evidence-based asthma care for providers.The study will be conducted in 26 primary care clinics of Kaiser Permanente Colorado (KPCO) using a pragmatic clinical trial design. Up to 15,000 high-risk asthma patients will be assigned to Breathe Well or guideline-based usual care based on their clinic.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

盲法说明

This is a pragmatic controlled trial. Participants randomized to the intervention group will know when they receive the intervention, which will consist of an automated contact by IVR call/text, or email.

入排标准

年龄范围
19 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults with ≥1 EHR of these indicators of an asthma care gap in the EHR will be eligible.
  • •B-agonist overfilling
  • •inhaled corticosteroid (ICS) underfilling
  • •current smoker
  • •asthma exacerbation in the last year

排除标准

  • •limited life expectancy
  • •diagnosis of chronic obstructive pulmonary disease
  • •lack of a pharmacy benefit because medication use cannot be captured.

研究组 & 干预措施

IVR call/text

Active Comparator

Identify gaps in care and contact patients by IVR phone call or text

干预措施: IVR call/text (Behavioral)

Email

Active Comparator

Identify gaps in care and contact patients by email

干预措施: Email (Behavioral)

结局指标

主要结局

Asthma Exacerbations

时间窗: 12 months

Defined as number of urgent care visits, hospitalizations, or prescriptions of an oral corticosteroid

次要结局

  • Controller medication adherence(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验